|
Volumn 57, Issue 1, 2002, Pages 45-51
|
General considerations for skin test procedures in the diagnosis of drug hypersensitivity
a b,c d a e f,g |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHISTAMINIC AGENT;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
CARBAMAZEPINE;
CEPHALOSPORIN DERIVATIVE;
CIPROFLOXACIN;
CORTICOSTEROID;
COTRIMOXAZOLE;
ERYTHROMYCIN;
GENTAMICIN;
GLUCOCORTICOID;
IMIPRAMINE;
OFLOXACIN;
PENICILLIN G;
PHENOTHIAZINE DERIVATIVE;
PRISTINAMYCIN;
TETRACYCLINE;
ALGORITHM;
ARTICLE;
CONCENTRATION RESPONSE;
DIAGNOSTIC PROCEDURE;
DIAGNOSTIC VALUE;
DRUG HYPERSENSITIVITY;
EVALUATION;
HIGH RISK POPULATION;
HUMAN;
INFORMED CONSENT;
MEDICAL ETHICS;
PATIENT SELECTION;
PRIORITY JOURNAL;
PROVOCATION TEST;
SCORING SYSTEM;
SENSITIVITY AND SPECIFICITY;
SKIN TEST;
TECHNIQUE;
|
EID: 0036166185
PISSN: 01054538
EISSN: None
Source Type: Journal
DOI: 10.1046/j.0105-4538.2001.00001.x-i8 Document Type: Article |
Times cited : (751)
|
References (20)
|